|Articles|February 11, 2022
- Applied Clinical Trials-02-01-2022
- Volume 31
- Issue 1/2
Applied Clinical Trials January/February 2022 Issue (PDF)
Click the title above for a link to open the Applied Clinical Trials January/February 2022 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 4 years ago
Tech Integration for Clinical Trialsalmost 4 years ago
Integrating Technology and Expertisealmost 4 years ago
Salary Survey: The Age of COVIDalmost 4 years ago
A(nother) New Start for Trial Regulations in Europe?almost 4 years ago
A Lesson Learned in Patient Centricityalmost 4 years ago
In Memoriam: Michael J. Hennessy, Sr. (1960-2021)almost 4 years ago
Concerns Mount Over Limited Evidence for Accelerated Approvalsalmost 4 years ago
Asian Biotech Clinical Trial Demand Moves to the Westalmost 4 years ago
Creating Future-Ready Teams for Digital Clinical TrialsNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
AbbVie and Genmab Secure FDA Approval for Epkinly Combination in Second-Line Plus Follicular Lymphoma
2
The Future is Now: Four Ways AI and Other Tech Advances are Enhancing Clinical Trials
3
Managing Operational and Compliance Challenges on Emerging Platforms
4
Ziihera Combinations Show Significant Survival Benefits in Phase III HER2+ GEA Trial
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
